PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL)

Name: PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL)
License: Public Domain

European Organisation for Research and Treatment of Cancer - EORTC

ClinicalTrials.gov · Datasets · License: Public Domain

lymphoma, t-cell, cutaneous, mycosis fungoides/sezary syndrome

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 405141
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.